CLINICAL_TRIALS
trial_result
· 2013-05-15
Clinical Trial Update: Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer [Phase 2]
Summary
Phase 2 clinical trial update of irofulven in patients with recurrent or metastatic gastric cancer. The study is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cancer Therapeutics Research Group | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED